Help Patients Safely Handle Medications to Improve Adherence by Maxik, Kenneth et al.
Marshall University 
Marshall Digital Scholar 
Management Faculty Research Management and Health Care Administration 
11-2021 




Follow this and additional works at: https://mds.marshall.edu/mgmt_faculty 
 Part of the Pharmacy and Pharmaceutical Sciences Commons 
SAFE HANDLING OF HAZARDOUS DRUGS
DIRECTIONS IN HEALTH-SYSTEM PHARMACY™
NOVEMBER  202118
M EDICATION NONADHERENCE CAN cause many drug-related adverse effects (AEs), and pharmacists are 
in a prime position to use every patient 
interaction as an opportunity to address 
barriers, improve adherence, and increase 
the safe management of medications.  
A common reason for nonadherence 
is complex medication regimens with 
multiple medications to treat multiple 
chronic disease states, posing a safety 
risk for patients. Complexity means 
patients can get confused, miss doses, or 
take them inappropriately. For example, 
in patients with diabetes and hyperten-
sion, overall adherence rates were within 
the range of 50% to 60%.1 The causes are 
so multifactorial that the World Health 
Organization (WHO) has broken down 
the reasons for patients not following 
the recommended treatment regimen into 
factors. These include economic and 
social factors, as well as those related to 
the health care system, the patient, the 
provider, and the therapy.2 
Briesacher et al examined adherence 
rates among patients with diabetes, gout, 
hypercholesterolemia, hypertension, 
hypothyroidism, osteoporosis, and seizure 
disorders and found that the rates varied 
from 36.8% to 72.3%.3 Yeaw et al eval-
uated adherence rates among patients on 
angiotensin II receptor blockers, bisphos-
phonates, oral antidiabetic medication, 
overactive bladder medication, prosta-
glandin analogues, and statins. After  
12 months, adherence rates ranged from 
35% to 72%.4 
The WHO said that, on average, adher-
ence among individuals experiencing 
chronic disease was 50%.5 This nonadher-
ence to prescribed therapy is estimated 
to generate at least 100,000 preventable 
deaths and $100 billion in preventable 
direct and indirect medical costs per year.5 
The Kaiser Family Foundation reported 
that nearly 1 in 4 Americans who takes 
prescription medications finds it challenging 
to afford them, and 29% of older adults 
said they did not take their medicines as 
prescribed because of the expense.6   
Pharmacists can help patients safely 
take their medications by addressing any 
barriers during each interaction with the 
patient. Patient-related barriers include 
cognitive impairment, cultural issues, 
denial, depression, and lack of health 
literacy and motivation.1 Treatment-re-
lated barriers include complexity of treat-
ment, cost, fear of AEs, inconvenience, 
and time.1 Others include an asymptom-
atic disease being treated or an inadequate 
patient-practitioner relationship.1
Strategies for Improvement
Pharmacist and team-based or coordinated 
care interventions have been shown to 
improve medication adherence rates and 
patient safety. Neiman et al reported that 
patients assigned to team-based care, 
including collaborative care between a 
cardiologist or primary care provider and 
a pharmacist; pharmacist-led medication 
reconciliation and tailoring; pharma-
cist-led patient education; and  
2 types of voice messaging (educational 
and medication refill reminder calls), 
were significantly more adherent with 
their medication regimen 12 months after 
hospital discharge (89%) than patients not 
receiving team-based care (74%). Patients 
reported that team-based care improved 
their comfort in asking clarifying ques-
tions, raising concerns about their medica-
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tion regimen, and collaborating to develop 
their treatment plan.7
Countless low-tech strategies for 
improving adherence have been demon-
strated to be helpful in studies that 
are typically of short duration. Such 
strategies include bundling medication 
refills together so patients can pick up 
all medications at the same time, clar-
ifying medication ingestion schedules, 
discussing the value of medications 
with patients, prescribing less expensive 
equivalent or generic medications, tele-
phone outreach, and verifying adherence 
by checking blood levels. In some 
disease populations, including patients 
with AIDS or tuberculosis, pharmacists 
have used email, telephone calls, and 
text messaging. When promoting adher-
ence to antiretroviral therapy, birth 
control, and prenatal vitamins, some 
pharmacists have also used e-cards and 
text messaging.8
Close to 50 companies are developing 
technology to help patients with medi-
cation adherence, with many addressing 
patient safety. Some are placing ingestible 
sensors in pills. Other examples include 
alarms to remind patients when a scheduled 
medication should be taken and bottles 
with wireless technology to track the 
number of pills ingested. Notably, many 
of these solutions to nonadherence require 
the transmission of data about the patient’s 
medication use to 1 or more third parties. 
These include caregivers, family members, 
and health care professionals, who could 
then mediate in real time to help ensure 
that the patient takes the medication.8
Technology allows patients to safely 
manage their medications with electronic 
reminders, which helps them play an essen-
tial part in their self-care and increases 
patient safety.8
In addition, technology helps practi-
tioners, who often lack detailed infor-
mation about patients’ actual behaviors. 
For example, specific, sound adherence 
data can support practitioners’ efforts to 
explain why a medication failed to work 
as expected. 
Often, inpatients in skilled-nursing 
facilities or other environments, where 
medication distribution is complex and 
time-consuming, can no longer take medi-
cation on their own. In these instances, 
smart technology can be used to audit and 
track consumption, decreasing the number 
of health care professionals needed to 
monitor adherence.9
Conclusion
Pharmacists play an essential role in 
promoting the safe handling of medications 
and decreasing nonadherence. They can 
use new strategies to improve adherence 
and medication safety, often with minimal 
investment, and new technology can 
help pave the way. ■
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